Skip to main content

Select Drug Profiles

FDA Approvals, In the News

October 28, 2019 – Oncology News & Updates

Breast Cancer, FDA Approvals, In the News, Multiple Myeloma, Pediatric Cancer, Oncology

Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News

Original Research, Practice Management

Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States

Michael C. Runken, PharmD, Joshua M. Noone, PhD, Christopher M. Blanchette, PhD, MBA, Emily Zacherle, MS, Reuben Howden, PhD

Michael C. Runken, PharmD; Joshua M. Noone, PhD; Christopher M. Blanchette, PhD, MBA; Emily Zacherle, MS; Reuben Howden, PhD

Stakeholder Perspective

Shared Decision-Making and Payer Preferences: IVIG or SCIG Route of Administration?

Gary M. Owens, MD

by Gary M. Owens, MD

Original Research, Practice Management

Costs and Healthcare Resource Utilization Associated with Hospital Admissions of Patients with Metastatic or Nonmetastatic Prostate Cancer

Krishna Tangirala, MPH, Sreevalsa Appukkuttan, MPH, MBBS, Stacey Simmons, MD

Krishna Tangirala, MPH; Sreevalsa Appukkuttan, MPH, MBBS; Stacey Simmons, MD

No Outcome, No Income

David B. Nash, MD, MBA

David B. Nash, MD, MBA

Accountability Is Everything: Outcomes-Based Pharmaceutical Agreements

Javier Gonzalez, PharmD

Javier González, PharmD

Original Research, Cardiometabolic Health

Employer-Sponsored Wellness Programs for Hypertension and Dyslipidemia in a 2-Hospital Health System

Anne Misher, PharmD, BCACP, BC-ADM, CDE, Jessica Brown, PharmD, Christina Maguire, PharmD, Alix P. Schnibben, PharmD, BCACP, CTTS

Anne Misher, PharmD, BCACP, BC-ADM, CDE; Jessica Brown, PharmD; Christina Maguire, PharmD; Alix P. Schnibben, PharmD, BCACP, CTTS

Stakeholder Perspective

Benefits of Employer-Sponsored Wellness Programs for Chronic Diseases

F. Randy Vogenberg, RPh, PhD, FASHP

by F. Randy Vogenberg, PhD, FASHP

FDA on In Vitro Diagnostics, Vaping; Cost of Novel Treatments

FDA Approvals, Multiple Myeloma, In the News, Oncology

FDA Approves Darzalex Combination for First-Line Treatment of Transplant-Eligible Patients with Multiple Myeloma

The Healthcare Start-Up Nation

David B. Nash, MD, MBA

David B. Nash, MD, MBA

Page 45 of 244
Results 441 - 450 of 2438